Fundamentals in Urology (2021)

June 11, 2021 to June 13, 2021

Essential Urology for You Fundamentals in Urology 2021

Course Directors:  Tracey Krupski, MD, MPH and Nicole Miller, MD

AUA's Fundamentals in Urology  course is designed to apply basic science knowledge and principles in development of treatment algorithms. This course will provide attendees with valuable skills in developing a rational methodological approach to application of knowledge which will contribute to positive outcomes for patients. Attendees will discover the importance of the study of basic sciences and how it transfers into the lifelong learning process and medical practice. This course is designed to ensure a fundamental knowledge of the "why" behind a broad expanse of general urologic conditions. A thorough knowledge of the basic science behind the treatments will allow for better counseling and education of patients by all clinical urologic practitioners. New for 2021, a half-day program has been added specifically for Advanced Practice Providers (APP’s).


Attendees can choose between three options:

  1. Live Virtual Course Only*
  2. Bundle the Live Vitual Course + Webcast Upgrade - Most Popular Option!*
  3. Webcast Only

Select our most popular option and bundle the Live Virtual Course Only AND Webcast Upgrade for access to the live virtual course and the recorded webcast.


Online Modules included in all purchase options!

AUA's Fundamentals in Urology course features enhanced programming that allows registrants to access additional online learning resources and modules at the convenience of their home for less time away from the office! The online modules include webcasts of content that was removed or reduced from the live program. The online educational modules for 2021 will include the following content:

  • Uro-Ethics
  • Obstructive Uropathy
  • Applications Outcome
  • Renal Physiology
  • Urodynamics
  • Pathology

EARLY BIRD REGISTRATION – ON OR BEFORE APRIL 26, 2021

Membership Category

Live Virtual Course Only

Webcast Upgrade*

Webcast Only

AUA Member$525$150$525
AUA Non-Member$655$150$655

STANDARD REGISTRATION – ON OR AFTER APRIL 27, 2021

Membership Category

Live Virtual Course Only

Webcast Upgrade*

Webcast Only

AUA Member$655$175$525
AUA Non-Member$820$175$655

*Add to purchase of Live Virtual Course only.

Note:  No printed syllabus will be offered - an online syllabus will be available for all registrants.


Webcasts will be available to view on Friday, June 18, 2021.

Target Audience

  • Residents
  • Allied Health Professionals
  • Urologists

Learning Objectives

After attending this course, participants will be able to:

BPH and Stones

  • Demonstrate knowledge of the medical management of BPH and utilize and evidence-based approach for selecting the best therapy
  • Describe the basic pathophysiology of nephrolithiasis
  • Identify the indications and options for the medical evaluation of recurrent and first-time stone formers
  • Establish an effective algorithm for the medical management of nephrolithiasis
  • Articulate how the AUA guidelines inform surgical treatment decision making

Imaging for Urologists

  • Describe approach to MR imaging interpretation of various urologic organs with a focus on clinical conditions encountered in practice

Infections and Inflammation

  • Discuss the evaluation of a patient with recurrent UTI
  • Distinguish emphysematous pyelonephritis from other renal infections and differences in management
  • Recognize differences in presentation of acute febrile UTI in males and the impact on treatment
  • Identify who should be screened for asymptomatic bacteriuria
  • Apply the AUA Best Practice Statement to the use of prophylactic antibiotics for procedures
  • Identify the true incidence of IC/BPS and CP/CPPS in the US population
  • Identify what is currently believed about the pathophysiology of chronic pelvic pain
  • Describe how to use the AUA guidelines to develop a treatment plan for patients with IC/BPS and CP/CPPS
  • Review current research in pelvic pain and possible new treatment options

Infertility and Erectile Dysfunction

  • Review female reproductive biology in the infertile couple
  • Describe the rationale and approach to evaluation of the infertile male
  • Explain male reproductive anatomy and physiology
  • Describe a basic clinical overview of male reproductive medicine and surgery
  • Utilize a shared decision-making framework, review treatment modalities for erectile dysfunction and when these therapies are contraindicated

Pediatrics

  • Review salient concepts of vesicoureteral reflux, urinary tract obstruction and cryptorchidism with urology residents in the early stages of their urology residency training curriculum.
  • Explain the basic development of the lower and upper urinary tract including the bladder, kidney and ureters
  • Identify clinical situations that may be encountered if aberrant development occurs in any of the above organ systems

Complications of Urologic Surgery and Kidney Cancer I

  • Recognize complications of urologic procedures, pathophysiologic changes underlying these occurrences, and management strategies to limit patient morbidity
  • Recognize the genetic basis and clinical management/ surveillance of all types of kidney cancer
  • Understand how the molecular profile informs treatment decisions
  • Recognize the genetic basis and current clinical and surgical management of all types of localized as well as advanced kidney cancer
  • Apply recently released guideline information to diagnose, evaluate, and manage patients with small renal masses (SRMs)

Kidney Cancer II and Adrenal Physiology

  • Define the fundamentals of adrenal anatomy and physiology integrate into the care of the urologic patient
  • Apply AUA guideline on small renal masses to the diagnosis, evaluation and management of these lesions

Bladder Neurobiology and Pelvic Organ Prolapse

  • Analyze the systematic evaluation and identification of various types of urinary incontinence (UI) and Pelvic Organ Prolapse (POP) in the outpatient setting to offer appropriate interventions for treatment
  • Describe the anatomy, innervation and physiology of the lower urinary tract
  • Define findings and treatment considerations specific to neurological conditions

Bladder Cancer and Bowel Diversions

  • Understand the guidelines-based management of invasive and non-invasive bladder cancer
  • Recognize the importance of subtypes of bladder cancer and the role of specific therapies based on these molecular profiles
  • Discuss the rationale behind selection of segment of bowel used in urinary diversion
  • Explain the long-term consequences of metabolic changes after urinary diversion and how to mitigate them
  • Identify a myriad of complications in the cystectomy post op period

Prostate Cancer

  • Review the current status of screening for prostate cancer in the US and explain the role that various markers play in the early detection of the disease
  • Describe the history of M1 Prostate cancer therapies
  • Identify basics in ADT management
  • Discuss basic science and clinical outcomes of new therapies               

APP Half-Day Program

  • Describe the rationale and approach to the evaluation of the hypogonadal male
  • Review the evaluation of management of microscopic hematuria based on the AUA guidelines
  • Articulate a framework for the approach to PSA screening and how to manage referrals for prostate cancer
  • Review the regulatory aspects of coding
  • Describe the principles in management of patients with UTI (including special populations such as neurogenic bladder patients)
  • Instruct new learners on technical aspects of how to perform office cystoscopy and how to determine proficiency

Additional Information

PDF icon Remembering Our Roots_4.pdf

Course summary
Course opens: 
02/02/2021
Course expires: 
06/13/2024
Event starts: 
06/11/2021 - 6:30am EDT
Event ends: 
06/13/2021 - 12:30pm EDT
List Price:
$820.00
Rating: 
0

Scientific Agenda

Friday, June 11, 2021

6:45 – 7:45 am             Registration

7:45 – 8:00 am             Housekeeping Notes

Session 1:                       BPH and Stones

8:00 – 9:00 am            Nephrolithiasis I: Physiology, Metabolic Workup and Medical Management of Stone Disease

                                   Glenn M. Preminger, MD

9:00 – 9:45 am            Nephrolithiasis II:  Surgical Approaches to Stone Disease

                                       Glenn M. Preminger, MD

9:45 – 10:00 am          Break

10:00 – 11:00 am        BPH: Pathophysiology and Management (Medical/Surgical)

                                       Nicole L. Miller, MD, FACS

Session 2:                       Imaging for Urologists

11:00 am - Noon         MRI for Urologists

                                    Nabeel E. Sarwani, MD, FRCR, FSAR

Noon – 1:00 pm          Lunch & Learn with the Experts

Session 3: Infections and Inflammation

1:00 – 2:00 pm            Urologic Infections: Etiology, Patterns and Pathophysiology

                                        Michel A. Pontari, MD

2:00 – 3:00 pm            Interstitial Cystitis and Disorders of Pelvic Pain

                                        Robert J. Evans, MD, FACS

3:00 – 3:15 pm            Break

Session 4:  Infertility and Erectile Dysfunction

3:15 – 4:15 pm            Infertility and Reproductive Biology in Women and Men

                                        C. Tanrikut, MD, FACS

4:15 – 5:15 pm            Medical and Surgical Management of Erectile Dysfunction

                                        John Mulhall, MD

5:15 – 5:30 pm            Course Evaluation

Saturday, June 12, 2021     

7:30 –7:45 am             Housekeeping Notes – General Session

Session 5: Pediatrics

7:45 – 8:45 am            Embryology, Congenital Anomalies, and Disorders of Sexual Differentiation

                                       Patricio Gargollo, MD

8:45 – 9:45 am            Reflux, Obstruction, and Undescended Testes – Causes and Clinical Implications   

                                       Aseem R. Shukla, MD

9:45-10:00 am             Break

Session 6: Complications of Urologic Surgery and KIDNEY CANCER I

10:00 – 11:00 am        Complications of Urologic Surgery

                                        Jay D. Raman, MD, FACS

11:00 am – Noon         Genetics and Principles of Molecular Therapeutics of Kidney Cancer

                                        W. Marston Linehan, MD

Noon – 1:00 pm           Lunch & Learn with the Experts

Session 7: KIDNEY CANCER II and Adrenal physiology

1:00 pm – 2:00 pm      Diagnosis and Management of the Small Renal Mass

Mark Ball, MD

2:00 – 3:00 pm            Adrenal Physiology

                                        Benjamin Ristau, MD

3:00 – 3:15 pm            Break

Session 8: Bladder Neurobiology and Pelvic Organ Prolapse

3:15 – 4:15 pm            Lower Urinary Tract Neurobiology and Functional Bladder Disorders

                                       Gary E. Lemack, MD

4:15 – 5:15 pm            Pelvic Organ Prolapse and Stress Urinary Incontinence: Clinical Assessment and Surgical Management

                                       Jennifer T. Anger, MD, MPH

5:15 – 5:30 pm            Course Evaluation

Sunday, June 13, 2021

7:30 – 7:45 am            Housekeeping Notes

Session 9: Bladder Cancer and Bowel Diversions

7:45 – 8:45 am          Basic Science of Bladder Cancer

                                    Trinity J. Bivalacqua, MD

8:45 – 9:45 am          Bowel Diversions: Physiology Underlying Electrolyte Abnormalities

Tracey Krupski, MD, MPH

9:45 – 10:00 am          Break

Session 10: Prostate Cancer

10:00 11:00 am         PSA, Urine Markers and the Science of Cancer Screening

                                        Leonard G. Gomella, MD, FACS

11:00 am – Noon         Management of Advanced Prostate Cancer: Drugs, Mechanisms, Disease, Epidemiology and Molecular Mechanisms

                                        Michael B. Williams, MD, MS

Noon – 12:15 pm        Course Evaluation and Meeting Adjourn

 

APP Half-Day Program

 Saturday, June 12, 2021

7:30 –7:45 am             Housekeeping Notes – APP participants report to APP breakout room

7:45 –8:15 am             Hypogonadism:  Testosterone Replacement and Supplementation

                                       C. Tanrikut, MD, FACS

8:15 – 9:00 am                 Microhematuria:  New AUA Guidelines

                                            Jay D. Raman, MD

9:00 – 9:45 am            Nuts and Bolts of Managing PSA Referrals

                                       Stephen H. Culp, MD, PhD

9:45 – 10:00 am              Break

10:00 – 10:30 am        Urology Coding for APP’s

                                           Edna R. Maldonado, CPC, ACS-UR, AHIMA-ICD-10 Trainer

10:30 – 11:00 am             Recurrent UTI Patients:  Evaluation and Management for APP’s

                                            Michel A. Pontari, MD

11:00 – 11:45 am             APP Cystoscopy

                                             Christy Krieg, NP

11:45 – Noon                Evaluation and Feedback

Noon – 1:00 pm           Lunch with the Experts for APP’s (Others on Own)

1:00 pm                         Rejoin Afternoon General Session 7

**This Scientific Agenda is subject to change.**

 

Live Virtual
United States

This course will be presented in live virtual format - you will be provided with instructions on how to join the live course and how to access the online modules.

AUA Education Council Disclosures:  PDF icon Education Council Disclosures_ June 2021.pdf

AUA COI Work Group Disclosures:  PDF icon COI Review Work Group Disclosures_2021.pdf

All relevant financial relationships have been mitigated. 

AUA Office of Education Staff has nothing to disclose.

Course Co-director(s)

Tracey Krupski, MD

has no relevant financial relationships to disclose at this time.

Nicole Miller, MD

has a financial relationship (Other) with Karl Storz Endoscopy;.
has a financial relationship (Independent contractor) with Intuitive Surgical;.
has a financial relationship (Independent contractor) with Bard;.
has a financial relationship (Independent contractor) with Virtuoso Surgical;.
has a financial relationship (Independent contractor) with Boston Scientific Corporation;.
Faculty(s)

Jennifer Anger, MD

has no relevant financial relationships to disclose at this time.

Mark Ball, MD

has no relevant financial relationships to disclose at this time.

Trinity Bivalacqua, MD

has a financial relationship (Other) with ferring pharmaceutical;.
has a financial relationship (Independent contractor) with Cold Genesis;.
has a financial relationship (Independent contractor) with biogenesis;.

Stephen Culp, MD

has no relevant financial relationships to disclose at this time.

Robert Evans, MD,FACS

has a financial relationship (Stock) with urigen;.

Patricio Gargollo, MD

has a financial relationship (Other) with Intuitive Surgical;.

Leonard Gomella, MD

has a financial relationship (Independent contractor) with Merck Pharmaceuticals;.
has a financial relationship (Independent contractor) with Merck Manual;.
has a financial relationship (Independent contractor) with Canadian Journal of Urology;.
has a financial relationship (Independent contractor) with Wolters Kluwer;.
has a financial relationship (Independent contractor) with MDx Health;.
has a financial relationship (Independent contractor) with McGraw Hill;.

Christy Krieg, CUNP

has a financial relationship (Independent contractor) with New York University;.

Gary Lemack, MD

has a financial relationship (Independent contractor) with Urovant;.
has a financial relationship (Independent contractor) with Theranova;.
has a financial relationship (Independent contractor) with Contura;.
has a financial relationship (Independent contractor) with Blue Wind;.
has a financial relationship (Independent contractor) with Allergan;.

W. Marston Linehan, MD

has no relevant financial relationships to disclose at this time.

Edna Maldonado, CPC

has no relevant financial relationships to disclose at this time.

John Mulhall, MD

has a financial relationship (Independent contractor) with vault;.
has a financial relationship (Independent contractor) with the journal of sexual medicine;.

Michel Pontari, MD

has no relevant financial relationships to disclose at this time.

Glenn Preminger, MD

has a financial relationship (Independent contractor) with Endourological Society;.
has a financial relationship (Independent contractor) with UpToDate;.
has a financial relationship (Independent contractor) with SESAUA;.
has a financial relationship (Independent contractor) with Retrophin;.
has a financial relationship (Independent contractor) with Auris Health;.
has a financial relationship (Independent contractor) with Kalera Medical;.
has a financial relationship (Independent contractor) with Boston Scientific;.

Jay Raman, MD

has a financial relationship (Stock) with United Medical Systems, Inc.;.
has a financial relationship (Stock) with American Kidney Stone Management;.
has a financial relationship (Other) with Urogen Pharma;.

Benjamin Ristau, MD

has no relevant financial relationships to disclose at this time.

Nabeel Sarwani, MD

has no relevant financial relationships to disclose at this time.

Aseem Shukla, MD

has no relevant financial relationships to disclose at this time.

Cigdem Tanrikut, MD

has a financial relationship (Independent contractor) with Ferring Pharmaceuticals;.
has a financial relationship (Other) with New England Cryogenic Center;.

Michael Williams, MD

has a financial relationship (Independent contractor) with Pacific Edge Diagnostics;.
has a financial relationship (Independent contractor) with Ferring;.
has a financial relationship (Independent contractor) with Olympus;.
has a financial relationship (Other) with Astellas;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Astellas;.

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live and enduring activity for a maximum of 27.5 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


AUA PARTICIPANT INFORMATION & POLICIES

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

 
 
Status
Price
Title
$820.00Included
Please login or register to take this course.
$150.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

List Price:
$820.00
Please login or register to take this course.

EARLY BIRD REGISTRATION – ON OR BEFORE APRIL 26, 2021

 Live Course OnlyWebcast Upgrade, Live Course Only*Webcast
Only
 
AUA Member$525.00$150.00$525.00 
AUA Non-Member$655.00$150.00$655.00 

STANDARD REGISTRATION – ON OR AFTER APRIL 27, 2021

 Live Course OnlyWebcast Upgrade, Live Course Only*Webcast
Only
 
AUA Member$655.00$150.00$525.00 
AUA Non-Member$820.00$150.00$655.00 

*Includes registration for Fundamentals in Urology live course and course webcasts.
**Hard Copy syllabus is only for purchase for those attending the live course. No hard copy syllabus will be shipped.

Webcast will be available to view on Friday, June 18, 2021.


Cancellation Policy

Live Course: An administrative fee of 15% is assessed if registration is cancelled up to six weeks prior to the course. If registration is cancelled four to six weeks from the course, the cancellation fee is 50% of the registration fee paid. No registration fees will be refunded less than four weeks prior to the course.

Webcast: Cancellations must be made no later than one week prior to the live course. Subscription fees will not be refunded after the cancellation period. Purchases after the live course date are not eligible for a refund.

Registration Transfer: Customers switching from an option of lesser value to a higher value will be required to pay the difference in cost between the two options. Switching to an option of lesser value from a higher value must be made no later than six weeks prior to the course and will be subject to an administrative fee of 15% of the cost of the course from which they are transferring. Transfer of registration from a higher value option to an option of lesser value past six weeks prior to the course will not receive a refund.

Cancellations must be made in writing. Requests may be made via mail or fax to 410-689-3912. Questions? Call 1-800-908-9414 or email registration@AUAnet.org.

AUA Education & Research reserves the right to cancel this course if a minimum enrollment is not reached before May 7, 2021. If AUA Education & Research cancels this course, registration fees will be refunded in full and notification will be sent by May 7, 2021.


Attendee Information & Policies

AUA Anti-Harassment Policy

AUA Commitment: AUA is committed to providing a safe and productive meeting environment that fosters open dialogue and the exchange of scientific ideas and is free of harassment and discrimination. All meeting participants are expected to behave professionally and treat others with respect, follow venue rules, and alert AUA staff or security of any dangerous situations or anyone in distress.

Reporting Harassment: It is the policy of the AUA that all meeting participants will enjoy an environment free from discrimination, harassment or retaliation. Harassing or offensive behavior by meeting participants will not be tolerated. If an individual experiences or witnesses harassment, he or she should contact Janet Skorepa, AUA EVP, at jskorepa@AUAnet.org or Diane Bieri, AUA General Counsel, at dbieri@AUAnet.org or use a venue phone and ask for security if he or she feels unsafe. All complaints will be treated seriously and responded to promptly.

The AUA reserves the right to take any action deemed necessary and appropriate, including refusing or revoking the registration of any individual, without refund, as long as such refusal is consistent with applicable law and AUA policy.

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA).

Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, a written request should be submitted at least one month in advance. For additional assistance with your request please call 1-800-908-9414.